构建一个查模型,以获得功能性草药治疗活跃性性结肠炎,基于草药化合物点网络和免疫透分析
Haiya Ou1, Xiaopeng Ye1, Hongshu Huang1
1Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.
Naunyn-Schmiedeberg's archives of pharmacology
|December 20, 2023
概括
这项研究开发了一个模型来识别治疗性结肠炎 (UC) 的传统中医药 (TCM). 通过准五个核心基因,四种关键草药显示出活性UC的潜力,为药物开发提供了新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 对于性结肠炎 (UC) 的传统中医药 (TCM) 的治疗机制在很大程度上仍然不清楚.
- 开发有效的策略,使活跃的UC转变为缓解是一个重大的临床挑战.
研究的目的:
- 建立一个核心的草药查模型来识别TCM,可以帮助管理活跃的UC.
- 发现潜在的免疫调节标和UC治疗的有效草药.
主要方法:
- 差异基因表达分析 (GSE75214数据集) 和权重基因共同表达网络分析 (WGCNA) 用于识别活跃UC的关键基因.
- 来自ImmPort的免疫相关基因 (IRG) 和来自TCMSP的草药点信息的整合.
- 机器学习算法 (SVM-REF,随机森林,LASSO) 用于确定核心治疗目标.
- 进行了分子对接和动态模拟,以验证草药-化合物-点相互作用.
主要成果:
- 通过综合分析和机器学习确定了五个核心目标 (CXCL2,DUOX2,LYZ,MMP9,AGT).
- 建立了一个243种与这些目标相关的草药网络.
- 四种特定的草药Hedysarum Multijugum 马克西姆. (黄),Sophorae Flavescentis Radix (Kushen),Cotyledon Fimbriata Turcz. (黄),Sophorae Flavescentis Radix (Kushen),Cotyledon Fimbriata Turcz. (黄),Cotyledon Fimbriata Turcz. (黄),Sophorae Flavescentis Radix. (黄),Cotyledon Fimbriata Turcz. (黄),Cotyledon Fimbriata Turcz. (黄),Cotyledon Fimbriata Turcz. (黄),Cotyledon Fimbriata Turcz. (黄),Cotyledon Fimbriata Turcz. (黄),Cotyledon Fimbriata Turcz. (黄),Cotyledon Fimbriata Turcz. (Wasong) 和Granati Pericarpium (Shiliupi) 因其在活性UC中减轻腹痛和血液等症状的潜力而受到重视.
- 分子对接和模拟证实了这些草药中的化合物与各自的点之间的稳定相互作用.
结论:
- 该研究成功地确定了五个核心目标和四个关键的TCM草药,用于活性UC,提供了一个新的免疫调节视角.
- 这些发现为基于TCM的UC管理提供了理论基础,并激发了新的UC治疗方法的开发.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Drugs for Treatment of Ulcerative Colitis in IBD
145
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
145


